As a healthcare professional, you are already aware that the information collected from genetic testing can significantly improve the quality of care and increase the personalization of treatment you provide your patients. The future of genetic testing is now, but how do you sort through the science, the terminology and the insights to better understand how genetics and genetic testing not only impacts your patients but also your practice?

Join your LUGPA colleagues for our Ask a Genetic Counselor Forum (brought to you by Myriad Genetics), where a Certified Genetic Counselor will provide education and answer the questions you have. Discuss challenges, opportunities and controversies related to testing and the impact it can have on ordering physicians, patients and their families.  


 

ARCHIVE:

Originally presented in October 2022: 
Full workup of prostate cancer patients and the importance of industry partnership to get the genetic answers you need
(Available On Demand here)  

Originally presented in August 2022: 
Patients are looking for answers. Why you should talk to them about genetic testing 
(Available On Demand here)  


Originally presented in May 2022: 
Incorporating “no surprise billing” into informed consent 
(Available On Demand here) 

Originally presented in March 2022: 
Have you seen updated guidelines? How will you implement them? 
(Available On Demand here) 


Originally presented in April 2021: 
How Genetics Test Results Change Prostate Cancer Management 
(Available On Demand here

Originally presented in June 2021:  
Germline and Somatic Testing: When and How to Utilize Results
(Available On Demand here

Originally presented in September 2021: 
Patient Privacy, Informed Consent, and Liability.   
(
Available On Demand here

Originally presented in November 2021: 
Sharing Best Practices – From Identifying Patients to Protocol Integration.   
(Available On Demand here)  


 

 

Rob Finch is a Certified Genetic Counselor.  He graduated with a Masters Degree in Human Genetics from the University of Pittsburgh in May 2001.  Rob worked at Memorial Sloan-Kettering Cancer Center from May 2001 to September 2003, where he led the Hereditary Colorectal Cancer Registry, as well as provided risk assessment and genetic testing to patients through the Clinical Genetics Service.  In September 2003, Rob joined the Myriad Genetics Team, where he has served as a Regional Medical Specialist and Institutional Account Executive for the Oncology Division and currently serves as a Medical Science Liaison for the Urology Division. Rob works to educate and provide clinical support to healthcare providers who treat prostate cancer for Myriad’s myRisk, BRACAnalysis CDx, and Prolaris.

 

Ask a Genetic Counselor is brought to you by: